Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.

We list the best Gantt chart software, to make it simple and easy to better visualize and manage progress when dealing with larges projects. Gantt chart software can be a powerful weapon in a ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Novo Nordisk’s Saxenda has been recommended by NICE as ... product which requires dosing by injection every day. Ozempic is squaring off in the market against Eli Lilly’s Trulicity ...

Brandon Lake Last week Weeks at no. 1 Weeks on chart B.M.Lake, S.Furtick, B.W.Hastings, C.J.Brown M.Nichols Brandon Lake/Essential/PLG Biggest gain in digital sales Gains In Performance ...

Dosing a statin (rosuvastatin ... and the Hartford Hospital Cholesterol Management Center. Approximately 2600 charts were reviewed to identify patients receiving rosuvastatin EOD who previously ...

Please note, the data displayed for this chart reflects the title's midweek position only, peak positions on this chart also relate to midweek chart positions. Official Singles Chart Update data ...